Literature DB >> 17114433

Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.

Jia-Bin Sun1, Sukanya Raghavan, Asa Sjöling, Samuel Lundin, Jan Holmgren.   

Abstract

Oral administration of Ag coupled to cholera toxin B subunit (CTB) efficiently induces peripheral immunological tolerance. We investigated the extent to which this oral tolerance is mediated by CD25+CD4+ regulatory T cells (T(reg)). We found that total T(reg), KJ1-26+ T(reg) and CTLA-4+ T(reg) were all increased in Peyer's patches, mesenteric lymph nodes, and, to a lesser extent, in spleen of mice after intragastric administration of OVA/CTB conjugate, which also increased TGF-beta in serum. This could be abolished by co-administering cholera toxin or by treatment with anti-TGF-beta mAb. CD25+ T(reg), but also CD25-CD4+ T cells from OVA/CTB-treated BALB/c or DO11.10 mice efficiently suppressed effector T cell proliferation and IL-2 production in vitro. Following adoptive transfer, both T cell populations also suppressed OVA-specific T cell and delayed-type hypersensitivity responses in vivo. Foxp3 was strongly expressed by CD25+ T(reg) from OVA/CTB-treated mice, and treatment also markedly expanded CD25+Foxp3+ T(reg). Furthermore, in Rag1(-/-) mice that had adoptively received highly purified Foxp3-CD25-CD4+ OT-II T cells OVA/CTB feeding efficiently induced CD25+ T(reg) cells, which expressed Foxp3 more strongly than naturally developing T(reg) and also had stronger ability to suppress effector OT-II T cell proliferation. A remaining CD25- T cell population, which also became suppressive in response to OVA/CTB treatment, did not express Foxp3. Our results demonstrate that oral tolerance induced by CTB-conjugated Ag is associated with increase in TGF-beta and in both the frequency and suppressive capacity of Foxp3+ and CTLA-4+ CD25+ T(reg) together with the generation of both Foxp3+ and Foxp3-CD25- CD4+ T(reg).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114433     DOI: 10.4049/jimmunol.177.11.7634

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Development of monoclonal antibodies to detect bovine FOXP3 in PBMCs exposed to a staphylococcal superantigen.

Authors:  K S Seo; W C Davis; M J Hamilton; Y H Park; G A Bohach
Journal:  Vet Immunol Immunopathol       Date:  2008-10-17       Impact factor: 2.046

2.  Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice.

Authors:  Inge L Huibregtse; Eric V Marietta; Shadi Rashtak; Frits Koning; Pieter Rottiers; Chella S David; Sander J H van Deventer; Joseph A Murray
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

Review 3.  Tissue-based class control: the other side of tolerance.

Authors:  Polly Matzinger; Tirumalai Kamala
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

Review 4.  Novel vaccine development strategies for inducing mucosal immunity.

Authors:  Yoshiko Fujkuyama; Daisuke Tokuhara; Kosuke Kataoka; Rebekah S Gilbert; Jerry R McGhee; Yoshikazu Yuki; Hiroshi Kiyono; Kohtaro Fujihashi
Journal:  Expert Rev Vaccines       Date:  2012-03       Impact factor: 5.217

Review 5.  Regulatory functions of γδ T cells.

Authors:  Christian Peters; Dieter Kabelitz; Daniela Wesch
Journal:  Cell Mol Life Sci       Date:  2018-03-08       Impact factor: 9.261

6.  Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.

Authors:  Daisuke Tokuhara; Yoshikazu Yuki; Tomonori Nochi; Toshio Kodama; Mio Mejima; Shiho Kurokawa; Yuko Takahashi; Masanobu Nanno; Ushio Nakanishi; Fumio Takaiwa; Takeshi Honda; Hiroshi Kiyono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

7.  Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells.

Authors:  Hideaki Suzuki; Shinichi Sekine; Kosuke Kataoka; David W Pascual; Massimo Maddaloni; Ryoki Kobayashi; Keiko Fujihashi; Haruo Kozono; Jerry R McGhee; Kohtaro Fujihashi
Journal:  Gastroenterology       Date:  2008-05-15       Impact factor: 22.682

8.  Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery.

Authors:  Abdoreza Davoodi-Semiromi; Melissa Schreiber; Samson Nalapalli; Dheeraj Verma; Nameirakpam D Singh; Robert K Banks; Debopam Chakrabarti; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2009-12-28       Impact factor: 9.803

9.  Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis.

Authors:  Lisa M Bartnikas; Michael F Gurish; Oliver T Burton; Sabine Leisten; Erin Janssen; Hans C Oettgen; Jacqueline Beaupré; Christopher N Lewis; K Frank Austen; Stephanie Schulte; Jason L Hornick; Raif S Geha; Michiko K Oyoshi
Journal:  J Allergy Clin Immunol       Date:  2013-02       Impact factor: 10.793

10.  Gpr83 expression is not required for the maintenance of intestinal immune homeostasis and regulation of T-cell-dependent colitis.

Authors:  Christy Toms; Heidi Jessup; Claire Thompson; Dilair Baban; Kay Davies; Fiona Powrie
Journal:  Immunology       Date:  2008-05-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.